Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF146 (RNF146)

Target
RNF146
Molecular classification
Enzyme, E3 ubiquitin-protein ligase, RING finger protein family, PAR-binding protein
01

Overview

E3 ubiquitin-protein ligase RNF146 (RNF146) is an enzyme in the RING finger protein family that functions as a PAR-binding, ubiquitin ligase (E3 ligase). It specifically recognizes poly-ADP-ribosylated (PARsylated) substrates via its WWE domain, and mediates their ubiquitination and subsequent proteasomal degradation. RNF146 regulates several biological processes, notably the canonical Wnt signaling pathway through degradation of PARsylated Axin and tankyrase proteins, making it a positive regulator of Wnt signaling. It contributes to cell survival, DNA damage responses, and is neuroprotective by blocking parthanatos (PAR-induced cell death). Dysregulation or genetic alteration of RNF146 has been implicated in cancer, neurodegenerative disorders, and other pathogenic processes. RNF146 is located in the cytosol, nucleoplasm, and at the plasma membrane, and acts as a single-subunit, RING-type E3 ligase essential for targeted ubiquitin-mediated protein degradation in human cells.

Other names
Ring finger protein 146DKFZp434O1427dactylidindJ351K20.1IdunaRNF146RING-type E3 ubiquitin transferase RNF146
02

Mechanism of action

Drugs targeting the RNF146 axis may act by inhibiting PARsylation-dependent ubiquitination of proteins, thereby regulating Wnt signaling and protein turnover. Potential modulation of tankyrase activity, impacting RNF146-mediated degradation of Axin and β-catenin pathways.

03

Biological functions

Ubiquitin-protein transferase activityPoly-ADP-ribose (PAR) binding and recognitionUbiquitin-dependent protein catabolic processesRegulation of Wnt signaling pathwayDNA damage responseCell survivalNeuroprotection against parthanatos (PAR-induced cell death)Protein ubiquitination
04

Disease associations

CancerNeurodegenerative diseaseCherubismAlcohol-related birth defectsOther cellular stress/injury responses
05

Safety considerations

Potential for off-target effects impacting Wnt signaling (implicated in cell proliferation and cancer)Broad effects on protein degradation pathways may have complex cellular consequencesImpact on DNA repair and neuroprotection could result in unintended cell survival or death outcomes in therapy

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF146 (RNF146).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF146 (RNF146).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call